We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MPB:NASDAQMid Penn Bancorp Analysis

Data as of 2026-04-18 - not real-time

$34.32

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Mid Penn Bancorp is trading at $34.32, comfortably above its 20‑day ($32.72) and 50‑day ($32.69) moving averages and the 200‑day level ($30.50), confirming a bullish price trend. The MACD histogram remains positive (0.18) and the MACD line sits above its signal, while the RSI at 68 signals near‑term strength but approaches overbought territory. Volume is on an increasing trend, and the Fear & Greed Index is at an “Extreme Greed” 90, suggesting strong market optimism. Insider activity adds confidence, with three directors purchasing shares in late March, indicating alignment of management and shareholder interests.
Fundamentally, the bank delivers robust revenue growth of 33% and impressive operating margins (~46%) that translate into a healthy profit margin of 25%. Valuation metrics are attractive: a forward P/E of 8.6 and current P/E of 13.5 are well below the industry average of 17.7, while the price‑to‑book ratio sits under 1 (0.97). The dividend yield of 2.45% with a modest payout ratio (~32%) appears sustainable, and analysts project a modest upside to $36.5, roughly a 6% gain from current levels.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Price near short‑term resistance at $35.09
  • Elevated RSI indicating potential near‑term pullback
  • Bullish technical indicators (MACD, moving averages) support stability

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued multiples relative to industry peers
  • Strong revenue growth and high operating margins
  • Sustainable dividend yield providing income cushion

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistent earnings generation and modest leverage
  • Low beta indicating lower market volatility over time
  • Long‑term upside implied by DCF fair value and analyst targets

Key Metrics & Analysis

Financial Health

Revenue Growth33.10%
Profit Margin25.06%
P/E Ratio13.5
ROE7.66%
ROA0.97%
P/B Ratio1.0
Op. Cash Flow$80.0M
Industry P/E17.7

Technical Analysis

TrendBullish
RSI68.3
Support$30.78
Resistance$35.09
MA 20$32.72
MA 50$32.69
MA 200$30.50
MACDBullish
VolumeIncreasing
Fear & Greed Index90.21

Valuation

Fair Value$83.51
Target Price$36.50
Upside/Downside6.35%
GradeUndervalued
TypeBlend
Dividend Yield2.45%

Risk Assessment

Beta0.90
Volatility18.31%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.